Enclomiphene 25mg

Dragon Pharma Enclomiphene — Purified 25mg SERM for Advanced Recovery

Dragon Pharma Enclomiphene delivers 25 mg of purified Enclomiphene Citrate per tablet. This next-generation Selective Estrogen Receptor Modulator represents a refined evolution over traditional racemic Clomiphene mixtures.

By isolating the trans-isomer responsible for hypothalamic stimulation, this compound eliminates the zuclomiphene fraction associated with emotional volatility and extended clearance. The result is cleaner gonadotropin signaling and more predictable Post-Cycle Therapy outcomes.

Overview

Enclomiphene Citrate is the purified trans-isomer of Clomiphene, a non-steroidal triphenylethylene derivative with potent anti-estrogenic activity at the hypothalamic level.

Traditional Clomid contains equal parts enclomiphene and zuclomiphene. The zuclomiphene isomer exhibits weak estrogenic agonism and a prolonged elimination half-life, contributing to mood disturbances and visual side effects in sensitive individuals.

Dragon Pharma's purified formulation retains only the trans-isomer. This delivers concentrated luteinizing hormone and follicle-stimulating hormone stimulation without the baggage of the estrogenic counterpart.

The compound blocks estrogen receptors in the hypothalamus and anterior pituitary. This perceived deficit triggers a compensatory cascade of gonadotropin-releasing hormone, driving testicular testosterone and sperm production.

Independent laboratory analysis confirmed 25.19 mg per tablet. This precision supports accurate dosing protocols and reliable pharmacological outcomes for both PCT and standalone testosterone enhancement.

Benefits

• Superior Gonadotropin Drive: Potently elevates luteinizing hormone and follicle-stimulating hormone secretion, commanding the testes to resume endogenous testosterone and spermatogenesis.
• Cleaner Neurological Profile: Absence of the zuclomiphene isomer eliminates the emotional lability, tearfulness, and visual disturbances commonly reported with racemic Clomiphene.
• Rapid Testosterone Restoration: Accelerates the return of physiological androgen levels, minimizing catabolic muscle loss and preserving hypertrophic gains from the active cycle.
• Fertility Preservation: Elevated FSH supports spermatogenesis and seminiferous tubule function, protecting reproductive capacity following extended anabolic exposure.
• Standalone Enhancement: Effective as an off-cycle testosterone optimizer for individuals seeking natural hormonal elevation without exogenous androgen administration.

Main Features

• Purified trans-isomer formulation at 25 mg per scored tablet
• Selective estrogen receptor modulator with hypothalamic antagonism
• Elimination of zuclomiphene-related estrogenic side effects
• Potent LH and FSH stimulation for HPTA recovery
• Compatible with Nolvadex stacking for comprehensive PCT
• Independent laboratory verification of active concentration

Ingredients

Each tablet contains 25 mg of Enclomiphene Citrate as the active pharmaceutical ingredient.

Inactive excipients include microcrystalline cellulose, lactose monohydrate, magnesium stearate, and pharmaceutical-grade binders. The scored design enables precise halving for flexible micro-dosing.

All raw materials undergo identity and purity validation prior to compression and packaging.

How to Use

Ingest tablets with water, with or without food. Morning administration is preferred to minimize any potential sleep disruption from increased hormonal activity.

For Post-Cycle Therapy, initiate only after exogenous steroids have cleared systemic circulation. Long-estered compounds typically require a 2–3 week waiting period following the final injection.

Store the container in a cool, dry environment between 15–25°C (59–77°F). Protect from moisture and direct light. Keep the desiccant pouch intact.

Dosage

The standard PCT protocol utilizes 25 mg daily for the first 2–3 weeks. This loading phase provides a powerful initial stimulus to the hypothalamic-pituitary-testicular axis.

Weeks 3–6 taper to 12.5 mg daily. This maintenance dose sustains recovery momentum while the body's autonomous hormone production regains full function.

Following mildly suppressive cycles with compounds like Primobolan or Oxandrolone, 12.5 mg daily for 4 weeks may prove sufficient.

For standalone testosterone enhancement off-cycle, 12.5 mg daily or every other day for 4–6 weeks supports natural elevation. Follow with an equal break period before reassessing.

The scored tablets allow clean halving without crumbling, ensuring accurate 12.5 mg administration.

Side Effects

Mild headaches may occur during the initial adaptation phase as hormone levels fluctuate. These typically resolve within the first week of administration.

Some users report restlessness or mild insomnia. Taking the dose earlier in the day and avoiding late-evening administration often mitigates this effect.

As endogenous testosterone surges, mild androgenic manifestations such as increased skin oiliness or minor acne may emerge. These reflect successful pharmacological action rather than adverse toxicity.

Visual disturbances are extremely rare with purified Enclomiphene due to the absence of zuclomiphene. Discontinue immediately and seek ophthalmologic evaluation if any visual changes develop.

Transient hot flashes or mild emotional sensitivity may occur as estrogen receptor signaling adjusts. These are generally mild and self-limiting.

Safety Information

This product is intended exclusively for research purposes and use by qualified male adults under appropriate supervision. It is not suitable for minors, women, or individuals with pre-existing hepatic, renal, or ocular conditions.

Ophthalmologic evaluation is recommended before initiating therapy. Any visual changes during the protocol require immediate cessation and professional assessment.

Stacking with Nolvadex provides superior recovery outcomes than Enclomiphene alone. The dual SERM approach targets complementary pathways within the HPTA cascade.

Continue aromatase inhibitor therapy up until the first day of PCT. This prevents estrogen rebound as exogenous androgens clear, allowing SERMs to work more effectively.

Discontinue immediately and seek medical evaluation if severe headaches, persistent visual disturbances, or mood deterioration develop.